← All organizations
Highest phase reached
Phase 2
First clinical trial
Apr 24, 2018Last known activity
Jun 27, 2022
Timeline
2010s
- Jun 1, 2014
Evelo Biosciences— Founded
Drugs by trial phase (6 distinct, 11 trials)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (17)
- NCT05682222Lead sponsorPhase 1Jun 27, 2022
- NCT05439941Lead sponsorPhase 2Jun 6, 2022
- NCT05439941Study directorPhase 2Jun 6, 2022
- NCT05121480Lead sponsorPhase 2Nov 30, 2021
- NCT05121480Study directorPhase 2Nov 30, 2021
- NCT05066373Lead sponsorPhase 1Aug 9, 2021
- NCT04927195Lead sponsorPhase 1Feb 23, 2021
- NCT04603027Study directorPhase 2Sep 21, 2020
- NCT04603027Lead sponsorPhase 2Sep 21, 2020
- NCT04488575Lead sponsorPhase 2Aug 26, 2020
- NCT04488575Study directorPhase 2Aug 26, 2020
- NCT03775850Lead sponsorPhase 1/Phase 2Dec 19, 2018
- NCT03595683CollaboratorPhase 2Nov 30, 2018
- NCT03733353Study directorPhase 1Nov 19, 2018
- NCT03733353Lead sponsorPhase 1Nov 19, 2018
Details
- Founded
- Cambridge, MA, US Jun 1, 2014
- Last known activity
- Jun 27, 2022